Logo

Molecular Devices Posts Flat Q4 Revenue and R&D Spend as Profit Tumbles 31 Percent

Feb 01, 2007
NEW YORK (GenomeWeb News) — Molecular Devices today said fourth-quarter revenues remained virtually flat as R&D spending was unchanged and profit decreased 31 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $52.8 million from $52.7 million year over year.
 
Molecular Devices did not break out revenues by business unit.
 
R&D spending was flat at $6.3 million in both quarters.
 
The company said profit declined to $4 million from $5.8 million in the year-ago period.
 
Molecular Devices said it had around $22.8 million in cash and equivalents as of Dec. 31.
 
Last week MDS said it plans to acquire Molecular Devices for $615 million in cash.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.